OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

2.34
Delayed Data
As of 10:39am ET
 +0.045 / +1.96%
Today’s Change
1.92
Today|||52-Week Range
14.25
+2.18%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues8.6M11.7M4.9M4.8M
 
 
 
 
 
Depreciation And Amortization65.0K55.0K55.0K55.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses15.6M19.6M12.5M12.0M
 
 
 
 
 
Research And Development13.2M16.9M9.9M9.6M
 
 
 
 
 
Total Operating Expenses15.6M19.7M12.6M12.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.0M-7.9M-7.6M-7.2M
 
 
 
 
 
Extraordinary Credit334.0K0.00615.0K2.9M
 
 
 
 
Extraordinary Charge0.00-721.0K0.00-531.0K
 
 
 
Other Expenses-1.0K2.0K-4.0K-11.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-8.6M-7.0M-4.9M
 
 
 
 
 
Net Income-6.7M-8.6M-7.0M-4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.7M14.7M15.0M21.1M
 
 
 
 
 
Shares To Calculate EPS Diluted14.7M14.7M15.0M21.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.59-$0.47-$0.23
 
 
 
 
 
EPS Diluted-$0.45-$0.59-$0.47-$0.23
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account